Company Filing History:
Years Active: 2009-2015
Title: The Innovative Contributions of Stephen Gould
Introduction
Stephen Gould is a prominent inventor based in San Carlos, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of tyrosine kinase inhibitors. With a total of 10 patents to his name, his work has the potential to impact the treatment of various diseases, including cancer.
Latest Patents
Among his latest patents, one notable invention is related to tyrosine kinase inhibitors containing a zinc-binding moiety. This invention focuses on the treatment of tyrosine-related diseases and disorders, such as cancer, and highlights the potential of these derivatives to act as HDAC inhibitors. Another significant patent involves quinazoline-based EGFR inhibitors that also contain a zinc-binding moiety. These compounds demonstrate enhanced properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and are useful in treating EGFR-TK related diseases, including cancer.
Career Highlights
Stephen Gould has established himself as a key figure in the pharmaceutical industry through his innovative research and development efforts. His work at Curis, Inc. has allowed him to focus on creating effective treatments for serious health conditions. His dedication to advancing medical science is evident in the patents he has secured.
Collaborations
Stephen has collaborated with notable colleagues, including Changgeng Qian and Xiong Cai. These partnerships have contributed to the success of his research and the development of groundbreaking therapies.
Conclusion
In summary, Stephen Gould's contributions to the field of pharmaceuticals through his innovative patents and collaborations have the potential to significantly impact the treatment of cancer and other diseases. His work exemplifies the importance of innovation in advancing medical science.